Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | MSCI ACWI IMI Innovation Select Screened 200 |
| Investment focus | Equity, World, Social/Environmental |
| Fund size | CHF 5 m |
| Total expense ratio | 0.30% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Investment approach | Long-only |
| Sustainability | Yes |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in CHF) | 14.38% |
| Inception/ Listing Date | 12 July 2022 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | Xtrackers |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | State Street Custodial Services (Ireland) Limited |
| Investment Advisor | DWS Investments UK Limited |
| Custodian Bank | State Street Custodial Services (Ireland) Limited, Dublin 2 |
| Revision Company | Pricewaterhouse Coopers |
| Fiscal Year End | 31 December |
| Swiss representative | DWS CH AG |
| Swiss paying agent | Deutsche Bank (Suisse) SA |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Italy | 26.0% |
| Indextype | - |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | Yes |
| Securities lending counterparty |
| Mastercard, Inc. | 4.69% |
| Visa, Inc. | 4.64% |
| Apple | 4.63% |
| Vertex Pharmaceuticals | 4.60% |
| Microsoft | 4.48% |
| NVIDIA Corp. | 4.42% |
| Tesla | 4.29% |
| Roche Holding AG | 3.90% |
| Lonza Group AG | 2.95% |
| Amazon.com, Inc. | 2.85% |
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
| 0.00 CHF | 0.00 CHF | View offer* | |
| 0.00 CHF | 0.00 CHF | View offer* |
| YTD | +2.25% |
| 1 month | +6.20% |
| 3 months | +10.59% |
| 6 months | +0.36% |
| 1 year | +10.77% |
| 3 years | +38.45% |
| 5 years | - |
| Since inception (MAX) | +43.00% |
| 2025 | +0.32% |
| 2024 | +31.74% |
| 2023 | +19.99% |
| 2022 | - |
| Volatility 1 year | 14.38% |
| Volatility 3 years | 17.63% |
| Volatility 5 years | - |
| Return per risk 1 year | 0.75 |
| Return per risk 3 years | 0.65 |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -16.51% |
| Maximum drawdown 3 years | -24.62% |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -24.62% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | XNNV | - - | - - | - |
| Borsa Italiana | EUR | XNNV | XNNV IM XNNVEUIV | XNNV.MI XNNVEURINAV=SOLA | |
| London Stock Exchange | USD | XNNV | XNNV LN XNNVUSIV | XNNV.L XNNVUSDINAV=SOLA | |
| XETRA | EUR | XNNV | XNNV GY | XNNV.DE |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares Healthcare Innovation UCITS ETF | 864 | 0.40% p.a. | Accumulating | Sampling |
| Amundi MSCI Disruptive Technology UCITS ETF Acc | 155 | 0.45% p.a. | Accumulating | Full replication |
| WisdomTree Megatrends UCITS ETF USD | 53 | 0.50% p.a. | Accumulating | Full replication |
| VanEck Genomics and Healthcare Innovators UCITS ETF A | 11 | 0.35% p.a. | Accumulating | Full replication |
| WisdomTree Tech Megatrends UCITS ETF USD Acc | 6 | 0.50% p.a. | Accumulating | Sampling |